Status: current, Defined. Date: 31-Aug 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4601751000168115 | Dayvigo (lemborexant 5 mg) tablet, 3 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4601761000168118 | Dayvigo 5 mg tablet, 3, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dayvigo 5 mg tablet, 3, blister pack | Is a | Dayvigo 5 mg tablet, 3 | true | Inferred relationship | Some | ||
| Dayvigo 5 mg tablet, 3, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Dayvigo 5 mg tablet, 3, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Dayvigo 5 mg tablet, 3, blister pack | has TP | Dayvigo | true | Inferred relationship | Some | ||
| Dayvigo 5 mg tablet, 3, blister pack | has TPUU | Dayvigo 5 mg tablet | true | Inferred relationship | Some | 674162550 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Black Triangle Scheme reference set
Containered trade product pack reference set
FHIR